论文部分内容阅读
目的:观察稳斑汤联合增强型体外反搏治疗冠心病不稳定型心绞痛(痰瘀互结证)的临床疗效及对血清AngⅡ的影响。方法:将120例冠心病不稳定型心绞痛(痰瘀互结证)患者随机分为治疗组与对照组各60例,对照组采用西医基础治疗加稳斑汤治疗,治疗组在对照组治疗方案基础上应用体外反搏治疗,疗程均为4周,疗程前后根据CRF表评定两组受试者心绞痛症状积分、心绞痛症状疗效、中医证候积分、中医证候疗效,采用酶联免疫吸附法测定血清AngⅡ的含量。结果:疗程结束后,与治疗前相比,治疗组和对照组心绞痛症状积分、中医证候积分均有显著降低(P<0.05),血清AngⅡ含量均有显著降低(P<0.05),治疗组心绞痛症状积分、中医证候积分均显著低于对照组(P<0.05),血清AngⅡ含量显著低于对照组(P<0.05)。治疗组的心绞痛症状疗效、中医证候疗效均显著优于对照组(P<0.05)。结论:稳斑汤联合体外反搏能有效治疗冠心病不稳定型心绞痛,抑制血浆中AngⅡ的表达可能是其作用机制之一。
Objective: To observe the clinical efficacy of Wenban Decoction combined with enhanced external counterpulsation in the treatment of unstable angina pectoris (phlegm and blood stasis syndrome) and its effect on serum AngⅡ. Methods: A total of 120 patients with unstable angina pectoris (phlegm, blood stasis and cross-over card) were randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with Jiawen Ban Point Decoction Based on the use of external counterpulsation treatment, the course of treatment was 4 weeks before and after treatment according to the CRF table assessment of angina pectoris symptom scores, symptoms of angina pectoris, TCM syndrome scores, the efficacy of TCM syndromes, enzyme-linked immunosorbent assay Serum Ang Ⅱ content. Results: Compared with before treatment, angina symptom scores and TCM syndrome scores were significantly decreased (P <0.05) and serum Ang Ⅱ levels were significantly decreased in treatment group and control group (P <0.05) Angina symptom scores and TCM syndrome scores were significantly lower than those in the control group (P <0.05), while serum AngⅡ levels were significantly lower than those in the control group (P <0.05). The efficacy of angina pectoris and TCM syndrome in the treatment group were significantly better than those in the control group (P <0.05). Conclusion: The combination of Wenban Decoction and EECP can effectively treat unstable angina pectoris and inhibit Ang Ⅱ expression in plasma may be one of its mechanisms.